Clinical Trial Search

Primary: Cumulative Number of Subjects With Any of the Components of the Composite Endpoint: >2kg Increase in Body Weight (Office-based), >2 L Increase in Total Body Water…

Primary: Change From Baseline in the Average Minutes of Moderate and Vigorous Physical Activity (MVPA) at Week 1 — 249.2; 14.2 minutes — p=<0.001

Primary: Incidence of Implant Failure — 8; 17; 34; 41 Number of Participants with Implant Fail

Primary: Number of Patients With Change in the Diagnosis After POCUS Examination — 397 Participants

Primary: Proportion of Subjects With at Least 75% Improvement in PASI (PASI 75) — 14.0; 28.3; 23.0; 16.7 percentage of subjects — p=0.1011

Primary: Percentage of Patients Needing a Second Surgery — 0 Participants

Primary: Enamel Hardness — 348.4; 351.6; 354.5 Vickers hardness kg f/mm2 — p=0.231

Primary: Kinematic Analysis (Including ROM of Each L/E Joints、Change in Gait Speed in Gait Cycle、Change in Center of Mass、Stride Length) — 9; -2; 9; 2 percentage (relative change)

Primary: Safety Related Events for Cohorts 1A, 1B and 2B. — 4; 4; 5; 6 Participants

Primary: D' — 1.69; 1.93; 1.86; 1.92 d'

Primary: Percentage of Participants Experiencing Treatment-emergent Adverse Events (TEAEs) — 95 percentage of participants

Primary: Change From Baseline in the Tardive Dyskinesia Impact Scale (TDIS) Total Score at Week 24 — -8.0 score on a scale

Primary: Study Feasibility — 15 Participants

Primary: Dengue IgG Level — 108.9; 104.0; 158.5; 143.2 RU/ml — p=< 0.01

Primary: Number of Participants Agreeing to Proceed With Germline Testing Among Those Approached With the Educational Intervention. — 41 Participants